Microdosingessentially, taking a smaller dose of something than is normally prescribedhas taken off among some users of GLP-1 medications, including semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro)
In our gut, this binding increases insulin levels and reduces blood sugar levels
Several preclinical models and clinical studies also suggest their potential as a novel therapeutic strategy for managing pain symptoms
Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity
In contrast, a lack of sleep raises cortisol and inflammation, decreasing GLP-1 secretion and increasing hungermaking consistent, restorative sleep imperative for maintaining a healthy weight